3Huang C,Frishman WH.Systemic hypertension:the roles of salt,vascular Na+-K+-ATPase and the endogenous glysosides,ouaba-in and marinobufagenin[J].Cardiaol Rev,2012,20(3):619-621.
4Huang C,Miller RT.Novel Ca receptor signaling pathway forcontrol of renal ion transport[J].Curr Opin Nephrol Hypertens,2010,19(1):106-112.
9He FJ,Li J.Effect of modest salt reduction on blood pressure:ameta-analysis of randomized trials.Implications for public health[J].J Hum Hypertens,2002,16(11):761-770.
7Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension[J]. N Engl J Med, 2007,356: 1966-1978.
8Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) [J]. BMJ ,2007,334:885-896.
9Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of mild hypertension study. Final results: Treatment of mild hypertension study research group[J]. JAMA, 1993,270 : 713-724.
10Kawano Y, Ando K, Matsuura H, et al. Report of the working group for dietary salt reduction of the Japanese society of hypertension: (1) Rationale for salt restriction and salt-restriction target level for the management of hypertension[J]. Hypertens Res, 2007,30:879-886.
